DK1567018T3 - Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer - Google Patents

Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer

Info

Publication number
DK1567018T3
DK1567018T3 DK02783892T DK02783892T DK1567018T3 DK 1567018 T3 DK1567018 T3 DK 1567018T3 DK 02783892 T DK02783892 T DK 02783892T DK 02783892 T DK02783892 T DK 02783892T DK 1567018 T3 DK1567018 T3 DK 1567018T3
Authority
DK
Denmark
Prior art keywords
lactobacillus reuteri
mammals
strains
immune function
improving immune
Prior art date
Application number
DK02783892T
Other languages
Danish (da)
English (en)
Inventor
Ho-Jin Kang
Ik-Boo Kwon
Eamonn Connolly
Bo Moellstam
Dong-Seog Lee
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Application granted granted Critical
Publication of DK1567018T3 publication Critical patent/DK1567018T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK02783892T 2002-10-18 2002-10-18 Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer DK1567018T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2002/001903 WO2004034808A1 (en) 2002-10-18 2002-10-18 Method of improving immune function in mammals using lactobacillus reuteri strains

Publications (1)

Publication Number Publication Date
DK1567018T3 true DK1567018T3 (da) 2009-09-14

Family

ID=32105771

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02783892T DK1567018T3 (da) 2002-10-18 2002-10-18 Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer

Country Status (12)

Country Link
US (1) US20060002907A1 (de)
EP (1) EP1567018B1 (de)
JP (1) JP2006506371A (de)
CN (1) CN100348119C (de)
AT (1) ATE434940T1 (de)
AU (1) AU2002347697B2 (de)
BR (1) BR0215884A (de)
DE (1) DE60232827D1 (de)
DK (1) DK1567018T3 (de)
ES (1) ES2329020T3 (de)
MX (1) MXPA05003743A (de)
WO (1) WO2004034808A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
ZA200705844B (en) * 2004-12-15 2008-09-25 Van Der Westhuzen Corne Floris Detoxifying and immunity-booster composition
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US7910127B2 (en) * 2007-03-02 2011-03-22 Biogaia Ab Use of lactic acid bacteria for improving food lysine absorption of pet animals
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
EP3139940B1 (de) * 2014-05-05 2021-02-17 Probiotical S.p.A. Zusammensetzung enthaltend l. reuteri ler03 and l. salivarius ls06 zur verwendung in der behandlung von tumoren, aids und leukämien
WO2015170159A1 (en) 2014-05-05 2015-11-12 Giovanni Mogna A composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising l. reuteri ler03 and/or l. salivarius ls06.
GB201812079D0 (en) * 2018-07-24 2018-09-05 Biogaia Ab Selection method
AU2020352646B2 (en) * 2019-09-26 2025-09-04 Precisionbiotics Group Limited Lactobacillus reuteri
AU2021380725A1 (en) * 2020-11-10 2023-07-06 Elanco Us Inc. Immunogenic probiotic compositions and methods of use including in vaccination
CN113073066B (zh) 2021-04-16 2022-01-04 段云峰 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN113881597B (zh) * 2021-10-15 2023-04-28 江南大学 一株能够提高吲哚丙烯酸以调节特异性IgE的罗伊氏乳杆菌

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139107A1 (en) * 1992-06-25 1994-01-06 Walter J. Dobrogosz Method of stimulating the immune system
DE69627994D1 (de) * 1995-12-21 2003-06-12 Biogaia Ab Stockholm Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren
DE29724815U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter

Also Published As

Publication number Publication date
ES2329020T3 (es) 2009-11-20
AU2002347697A1 (en) 2004-05-04
MXPA05003743A (es) 2005-06-17
DE60232827D1 (de) 2009-08-13
HK1079661A1 (en) 2006-04-13
US20060002907A1 (en) 2006-01-05
CN100348119C (zh) 2007-11-14
WO2004034808A1 (en) 2004-04-29
BR0215884A (pt) 2005-12-20
AU2002347697B2 (en) 2008-03-20
EP1567018B1 (de) 2009-07-01
JP2006506371A (ja) 2006-02-23
ATE434940T1 (de) 2009-07-15
EP1567018A1 (de) 2005-08-31
CN1668211A (zh) 2005-09-14

Similar Documents

Publication Publication Date Title
AU2013205271B2 (en) Human CGRP receptor binding proteins
MX2009003306A (es) Anticuerpos humanos que se unen a cxcr4 y sus usos.
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
WO2001021766A8 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
MY163480A (en) Sclerostin binding agents
SG196798A1 (en) Anti-pd-l1 antibodies and their use to enhance t-cell function
WO2005121331A3 (en) Truncated galnact2 polypeptides and nucleic acids
MX351247B (es) Composiciones inmunogenicas que comprenden polipeptidos de mycobacterium tuberculosis y fusiones de los mismos.
MX337041B (es) Cepas y metodos para mejorar la salud y/o desempeño de los rumiantes.
MX348432B (es) Epitopes.
MY183134A (en) Anti-cemx antibodies capable of binding to human mlge on b lymphocytes
TN2009000380A1 (en) Novel human anti-r7v antibodies and uses thereof
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
MY160041A (en) Compositions and methods for treating parasitic infections
EP1553975B8 (de) Optimierte fc-varianten und herstellungsverfahren dafür
WO2008063675A3 (en) Endodermal progenitor cells
WO2007041171A3 (en) Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
DK2054431T3 (da) Konformere af bakterielle adhæsiner
BR0215884A (pt) Método para melhorar a função imunológica em mamìferos usando cepas de lactobacillus reuteri
WO2008108830A3 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
WO2021262597A3 (en) Lair-1-binding agents and methods of use thereof
NZ602515A (en) Proteins that bind pi16 and uses thereof
WO2003075953A3 (en) Immunomodulatory polymeric antigens for treating inflammatory pathogies